These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 18339181)

  • 1. Biomarkers for lysosomal storage disorders: identification and application as exemplified by chitotriosidase in Gaucher disease.
    Aerts JM; van Breemen MJ; Bussink AP; Ghauharali K; Sprenger R; Boot RG; Groener JE; Hollak CE; Maas M; Smit S; Hoefsloot HC; Smilde AK; Vissers JP; de Jong S; Speijer D; de Koster CG
    Acta Paediatr; 2008 Apr; 97(457):7-14. PubMed ID: 18339181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and use of biomarkers in Gaucher disease and other lysosomal storage diseases.
    Aerts JM; Hollak CE; van Breemen M; Maas M; Groener JE; Boot RG
    Acta Paediatr Suppl; 2005 Mar; 94(447):43-6; discussion 37-8. PubMed ID: 15895711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers in the diagnosis of lysosomal storage disorders: proteins, lipids, and inhibodies.
    Aerts JM; Kallemeijn WW; Wegdam W; Joao Ferraz M; van Breemen MJ; Dekker N; Kramer G; Poorthuis BJ; Groener JE; Cox-Brinkman J; Rombach SM; Hollak CE; Linthorst GE; Witte MD; Gold H; van der Marel GA; Overkleeft HS; Boot RG
    J Inherit Metab Dis; 2011 Jun; 34(3):605-19. PubMed ID: 21445610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of amniotic fluid chitotriosidase in the prenatal diagnosis of lysosomal storage disorders.
    Kadali S; Madalasa T; Reddy GM; Naushad SM
    Clin Biochem; 2018 Nov; 61():40-44. PubMed ID: 30205089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers in lysosomal storage diseases: a review.
    Cox TM
    Acta Paediatr Suppl; 2005 Mar; 94(447):39-42; discussion 37-8. PubMed ID: 15895710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chitotriosidase activity as additional biomarker in the diagnosis of lysosomal storage diseases.
    Olkhovych NV
    Ukr Biochem J; 2016; 88(1):69-78. PubMed ID: 29227082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Plasma chitotriosidase activity in Argentinian patients with Gaucher disease, various lysosomal diseases and other inherited metabolic disorders].
    Dodelson de Kremer R; Paschini de Capra A; Angaroni CJ; Giner de Ayala A
    Medicina (B Aires); 1997; 57(6):677-84. PubMed ID: 9674188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modelling long-term evolution of chitotriosidase in non-neuronopathic Gaucher disease.
    Drugan C; Drugan TC; Grigorescu-Sido P; Naşcu I
    Scand J Clin Lab Invest; 2017 Jul; 77(4):275-282. PubMed ID: 28319420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gaucher disease: a model disorder for biomarker discovery.
    Boot RG; van Breemen MJ; Wegdam W; Sprenger RR; de Jong S; Speijer D; Hollak CE; van Dussen L; Hoefsloot HC; Smilde AK; de Koster CG; Vissers JP; Aerts JM
    Expert Rev Proteomics; 2009 Aug; 6(4):411-9. PubMed ID: 19681676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated plasma chitotriosidase activity in various lysosomal storage disorders.
    Guo Y; He W; Boer AM; Wevers RA; de Bruijn AM; Groener JE; Hollak CE; Aerts JM; Galjaard H; van Diggelen OP
    J Inherit Metab Dis; 1995; 18(6):717-22. PubMed ID: 8750610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma chitotriosidase activity versus CCL18 level for assessing type I Gaucher disease severity: protocol for a systematic review with meta-analysis of individual participant data.
    Raskovalova T; Deegan PB; Yang R; Pavlova E; Stirnemann J; Labarère J; Zimran A; Mistry PK; Berger M
    Syst Rev; 2017 Apr; 6(1):87. PubMed ID: 28427477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chitotriosidase of human macrophages and mammalian chitinases: biological functions and abnormalities in pathology].
    Korolenko TA; Cherkanova MS
    Vestn Ross Akad Med Nauk; 2009; (11):39-45. PubMed ID: 20017407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening patients referred to a metabolic clinic for lysosomal storage disorders.
    Fuller M; Tucker JN; Lang DL; Dean CJ; Fietz MJ; Meikle PJ; Hopwood JJ
    J Med Genet; 2011 Jun; 48(6):422-5. PubMed ID: 21415080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood spot versus plasma chitotriosidase: a systematic clinical comparison.
    Elmonem MA; Ramadan DI; Issac MS; Selim LA; Elkateb SM
    Clin Biochem; 2014 Jan; 47(1-2):38-43. PubMed ID: 24177195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of chitotriosidase enzyme activity in Gaucher and Niemann Pick A/B diseases: A retrospective study from India.
    Kadali S; Kolusu A; Sunkara S; Gummadi MR; Undamatla J
    Clin Chim Acta; 2016 Jun; 457():8-11. PubMed ID: 26975750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass spectrometry-based proteomics in neurodegenerative lysosomal storage disorders.
    Li W; Cologna SM
    Mol Omics; 2022 May; 18(4):256-278. PubMed ID: 35343995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzymatic analysis of biomarkers for the monitoring of Gaucher patients in Colombia.
    Pacheco N; Uribe A
    Gene; 2013 May; 521(1):129-35. PubMed ID: 23523857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of a comprehensive protocol for the identification of Gaucher disease in Brazil.
    Michelin K; Wajner A; de Souza FT; de Mello AS; Burin MG; Pereira ML; Pires RF; Giugliani R; Coelho JC
    Am J Med Genet A; 2005 Jul; 136(1):58-62. PubMed ID: 15937950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LC-MS/MS analysis of plasma glucosylsphingosine as a biomarker for diagnosis and follow-up monitoring in Gaucher disease in the Spanish population.
    Irún P; Cebolla JJ; López de Frutos L; De Castro-Orós I; Roca-Espiau M; Giraldo P
    Clin Chem Lab Med; 2020 Apr; 58(5):798-809. PubMed ID: 32126008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of neopterin as a biomarker for the monitoring of Gaucher disease patients.
    Drugan C; Drugan TC; Miron N; Grigorescu-Sido P; Naşcu I; Cătană C
    Hematology; 2016 Jul; 21(6):379-86. PubMed ID: 26903266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.